| Literature DB >> 26793233 |
Delphine Vincent1, Vilnis Ezernieks1, Aaron Elkins1, Nga Nguyen1, Peter J Moate2, Benjamin G Cocks3, Simone Rochfort3.
Abstract
Milk is a complex fluid whose proteome displays a diverse set of proteins of high abundance such as caseins and medium to low abundance whey proteins such as ß-lactoglobulin, lactoferrin, immunoglobulins, glycoproteins, peptide hormones, and enzymes. A sample preparation method that enables high reproducibility and throughput is key in reliably identifying proteins present or proteins responding to conditions such as a diet, health or genetics. Using skim milk samples from Jersey and Holstein-Friesian cows, we compared three extraction procedures which have not previously been applied to samples of cows' milk. Method A (urea) involved a simple dilution of the milk in a urea-based buffer, method B (TCA/acetone) involved a trichloroacetic acid (TCA)/acetone precipitation, and method C (methanol/chloroform) involved a tri-phasic partition method in chloroform/methanol solution. Protein assays, SDS-PAGE profiling, and trypsin digestion followed by nanoHPLC-electrospray ionization-tandem mass spectrometry (nLC-ESI-MS/MS) analyses were performed to assess their efficiency. Replicates were used at each analytical step (extraction, digestion, injection) to assess reproducibility. Mass spectrometry (MS) data are available via ProteomeXchange with identifier PXD002529. Overall 186 unique accessions, major and minor proteins, were identified with a combination of methods. Method C (methanol/chloroform) yielded the best resolved SDS-patterns and highest protein recovery rates, method A (urea) yielded the greatest number of accessions, and, of the three procedures, method B (TCA/acetone) was the least compatible of all with a wide range of downstream analytical procedures. Our results also highlighted breed differences between the proteins in milk of Jersey and Holstein-Friesian cows.Entities:
Keywords: Jersey and Holstein-Friesian cow milk; proteome; replicates; shotgun nLC-ESI-MS; trypsin digestion
Year: 2016 PMID: 26793233 PMCID: PMC4707256 DOI: 10.3389/fgene.2015.00360
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
Figure 1Overview of the experimental workflow. Two full cream milk samples were collected from bulk tanks containing the milk of the whole herd of Holstein-Friesian or Jersey cows milked on that particular day. Following centrifugation of the milk to eliminate the cream, proteins were extracted from skim milk in triplicates (e1-e3) using methods A (urea), B (TCA/acetone), or C (methanol/chloroform). All 18 protein extracts were separated using SDS-PAGE, and their protein concentrations obtained in triplicates using the BCA assay. One hundred microgram proteins of each of the 18 extracts were trypsin-digested using five replicates (d1-d5). All 90 tryptic digests underwent Solid Phase Extraction (SPE) clean-up, ultrafiltration (UF) using a 30 kD MWCO; peptide concentrations were obtained using the BCA assay. One hundred nanogram peptides of each of the 90 digests were randomly injected for nLC-MS/MS analysis in triplicates (i1-i3) thus generating 270 MS result files.
List of protein accessions identified in the different milk extracts, along with their description, their coverage (percentage of the database protein sequence covered by matching peptides) across samples, the number of unique peptides (distinct peptide that match to a single protein entry within the search database), the occurrence (%) in the three methods and the two breeds.
| 1 | 11 kDa protein | 52.3 | 22 | 100 | 100 | 100 | 100 | 100 | ||
| 2 | 16.5 | 520 | 72 | 67 | 40 | 47 | ||||
| 3 | Alpha-1-acid glycoprotein | 33.7 | 10 | 97 | 100 | 27 | 77 | 75 | ||
| 4 | 24.5 | 10 | 97 | 94 | 85 | 87 | ||||
| 5 | 13.3 | 6 | 9 | 39 | 35 | 13 | ||||
| 6 | 19.2 | 8 | 86 | 74 | 65 | 62 | ||||
| 7 | Alpha-lactabumin | 30.8 | 3 | 95 | 0 | 55 | 50 | 51 | ||
| 8 | Alpha-lactalbumin | 9.9 | 1 | 7 | 0 | 0 | 5 | 0 | ||
| 9 | Alpha-lactalbumin | 18.1 | 2 | 100 | 100 | 100 | 100 | 100 | ||
| 10 | Alpha-lactalbumin | 31.0 | 53 | 55 | 0 | 0 | 18 | 21 | ||
| 11 | Alpha-lactalbumin-like isoform X3 | 12.3 | 3 | 100 | 0 | 0 | 36 | 34 | ||
| 12 | Alpha-S1-casein | 15.8 | 1 | 100 | 100 | 100 | 100 | 100 | ||
| 13 | Alpha-S1-casein | 64.7 | 1 | 0 | 1 | 0 | 0 | 1 | ||
| 14 | 14.0 | 1 | 22 | 12 | 17 | 11 | ||||
| 15 | Alpha-S1-casein isoform X2 | 41.3 | 47 | 100 | 100 | 100 | 100 | 100 | ||
| 16 | Alpha-S1-casein isoform X3 | 42.2 | 47 | 100 | 100 | 100 | 100 | 100 | ||
| 17 | Alpha-S1-casein isoform X6 | 30.2 | 5 | 100 | 100 | 100 | 100 | 100 | ||
| 18 | Alpha-S1-casein isoform X7 | 49.2 | 47 | 100 | 100 | 100 | 100 | 100 | ||
| 19 | Alpha-S2-casein | 59.5 | 29 | 0 | 4 | 10 | 5 | 4 | ||
| 20 | Alpha-S2-casein | 24.1 | 1 | 100 | 100 | 100 | 100 | 100 | ||
| 21 | 31.8 | 5 | 76 | 39 | 74 | 57 | ||||
| 22 | 9.5 | 5 | 51 | 6 | 35 | 21 | ||||
| 23 | Anti-hiv llama vhh antibody a12 | 6.3 | 1 | 0 | 0 | 1 | 0 | 1 | ||
| 24 | Apolipoprotein A-I preproprotein | 38.1 | 56 | 99 | 0 | 99 | 67 | 63 | ||
| 25 | 16.0 | 5 | 25 | 0 | 0 | 3 | ||||
| 26 | Apolipoprotein A-IV | 18.7 | 19 | 36 | 0 | 4 | 12 | 16 | ||
| 27 | Apolipoprotein E | 7.3 | 12 | 75 | 0 | 15 | 30 | 32 | ||
| 28 | ATP-binding cassette sub-family G member 2 | 7.9 | 80 | 100 | 0 | 81 | 62 | 59 | ||
| 29 | 5.1 | 2 | 90 | 29 | 0 | 29 | ||||
| 30 | Beta-1,4-galactosyltransferase 1 | 10.0 | 29 | 0 | 0 | 5 | 3 | 0 | ||
| 31 | Beta-2-microglobulin | 23.7 | 22 | 100 | 82 | 97 | 96 | 90 | ||
| 32 | Beta-casein | 23.7 | 8 | 0 | 0 | 81 | 27 | 23 | ||
| 33 | Beta-casein | 23.7 | 45 | 0 | 100 | 0 | 32 | 36 | ||
| 34 | Beta-casein variant I | 35.9 | 2 | 35 | 0 | 0 | 12 | 13 | ||
| 35 | Beta-lactoglobulin | 37.0 | 22 | 1 | 0 | 0 | 0 | 1 | ||
| 36 | Beta-lactoglobulin | 30.0 | 1 | 100 | 100 | 100 | 100 | 100 | ||
| 37 | Beta-lactoglobulin | 41.0 | 18 | 5 | 0 | 19 | 6 | 10 | ||
| 38 | Beta-lactoglobulin | 47.5 | 19 | 100 | 0 | 100 | 68 | 64 | ||
| 39 | Beta-lactoglobulin | 47.5 | 15 | 100 | 0 | 0 | 36 | 34 | ||
| 40 | Beta-lactoglobulin | 25.8 | 1 | 100 | 100 | 0 | 68 | 70 | ||
| 41 | Beta-lactoglobulin A | 47.5 | 22 | 100 | 0 | 0 | 36 | 34 | ||
| 42 | 9.4 | 1 | 22 | 0 | 0 | 2 | ||||
| 43 | Butyrophilin subfamily 1 member A1 | 28.1 | 335 | 100 | 100 | 100 | 100 | 100 | ||
| 44 | Cathelicidin-1 | 10.3 | 10 | 6 | 0 | 1 | 5 | 0 | ||
| 45 | 11.1 | 1 | 5 | 13 | 1 | 1 | ||||
| 46 | 14.1 | 23 | 25 | 0 | 81 | 22 | ||||
| 47 | CD81 antigen | 6.8 | 9 | 89 | 8 | 0 | 37 | 31 | ||
| 48 | Cell division control protein 42 homolog isoform 1 | 5.2 | 76 | 19 | 0 | 33 | 19 | 15 | ||
| 49 | Chemokine (C-X-C motif) ligand 3 | 14.4 | 9 | 95 | 0 | 0 | 34 | 33 | ||
| 50 | Clusterin preproprotein | 18.0 | 53 | 97 | 95 | 99 | 95 | 98 | ||
| 51 | Complement C3 | 7.9 | 86 | 100 | 100 | 100 | 100 | 100 | ||
| 52 | Complement C3 | 34.0 | 152 | 100 | 0 | 0 | 36 | 34 | ||
| 53 | Cysteine-rich secretory protein 3 | 23.4 | 7 | 99 | 78 | 90 | 91 | 87 | ||
| 54 | dnaJ homolog subfamily B member 9 | 17.9 | 89 | 0 | 20 | 13 | 8 | 13 | ||
| 55 | dnaJ homolog subfamily C member 3 | 3.4 | 14 | 0 | 0 | 1 | 1 | 0 | ||
| 56 | Dystroglycan | 1.8 | 21 | 0 | 91 | 1 | 32 | 30 | ||
| 57 | Endopin 2B | 16.6 | 7 | 92 | 0 | 0 | 35 | 29 | ||
| 58 | 32.9 | 8 | 59 | 80 | 8 | 38 | ||||
| 59 | 5.2 | 1 | 56 | 13 | 0 | 13 | ||||
| 60 | Factor XIIa inhibitor | 15.4 | 7 | 100 | 68 | 71 | 82 | 78 | ||
| 61 | Fatty acid synthase | 1.2 | 11 | 8 | 0 | 0 | 1 | 5 | ||
| 62 | 14.3 | 40 | 99 | 40 | 100 | 64 | ||||
| 63 | Fatty acid-binding protein | 47.4 | 109 | 80 | 0 | 9 | 34 | 28 | ||
| 64 | 8.9 | 7 | 95 | 28 | 63 | 48 | ||||
| 65 | 11.7 | 24 | 27 | 53 | 49 | 37 | ||||
| 66 | 11.5 | 5 | 94 | 40 | 92 | 63 | ||||
| 67 | Fibronectin isoform X10 | 0.6 | 484 | 0 | 0 | 3 | 0 | 2 | ||
| 68 | 9.1 | 4 | 76 | 74 | 0 | 44 | ||||
| 69 | Gelsolin isoform b | 1.8 | 190 | 0 | 11 | 0 | 2 | 5 | ||
| 70 | Glutamyltranspeptidase 1 gamma | 6.7 | 4 | 10 | 2 | 0 | 2 | 7 | ||
| 71 | Glycosylation-dependent cell adhesion molecule 1 | 50.3 | 39 | 100 | 100 | 100 | 100 | 100 | ||
| 72 | GTP binding protein Rab1a | 17.0 | 118 | 0 | 1 | 37 | 16 | 8 | ||
| 73 | hCG1791766 isoform CRA_a | 13.7 | 2 | 0 | 18 | 47 | 22 | 20 | ||
| 74 | Heat shock cognate 71 kDa protein | 5.9 | 656 | 14 | 0 | 0 | 4 | 6 | ||
| 75 | Heat shock-related 70 kDa protein 2 | 1.7 | 1 | 0 | 1 | 19 | 8 | 5 | ||
| 76 | Hedgehog interacting protein-like 2-like | 11.5 | 10 | 0 | 80 | 96 | 60 | 54 | ||
| 77 | Hemopexin | 3.5 | 6 | 2 | 0 | 0 | 2 | 0 | ||
| 78 | Heparin cofactor 2 | 2.6 | 6 | 0 | 5 | 0 | 1 | 2 | ||
| 79 | 39.7 | 2 | 13 | 12 | 88 | 28 | ||||
| 80 | Hornerin | 4.1 | 6 | 0 | 0 | 1 | 0 | 1 | ||
| 81 | 12.6 | 1 | 1 | 0 | 59 | 13 | ||||
| 82 | Ig J chain | 29.9 | 20 | 99 | 100 | 99 | 98 | 100 | ||
| 83 | Ig lambda light chain | 21.3 | 10 | 100 | 0 | 100 | 68 | 64 | ||
| 84 | Ig lambda light chain constant region 2 allotypic variant IGLC2b | 30.2 | 1 | 98 | 100 | 0 | 67 | 69 | ||
| 85 | Ig lambda light chain constant region 3 allotypic variant IGLC3c | 52.8 | 3 | 100 | 100 | 100 | 100 | 100 | ||
| 86 | 13.9 | 2 | 0 | 0 | 19 | 1 | ||||
| 87 | Ig lambda-like polypeptide 1-like | 23.3 | 8 | 100 | 0 | 100 | 68 | 64 | ||
| 88 | Ig light chain | 16.7 | 3 | 91 | 62 | 77 | 80 | 74 | ||
| 89 | Ig light chain | 61.4 | 16 | 100 | 0 | 100 | 68 | 64 | ||
| 90 | Ig light chain variable region | 11.5 | 1 | 100 | 100 | 100 | 100 | 100 | ||
| 91 | Ig light chain variable region | 41.8 | 12 | 0 | 4 | 3 | 4 | 0 | ||
| 92 | Ig light chain variable region | 9.4 | 15 | 16 | 6 | 0 | 10 | 6 | ||
| 93 | Ig light chain, lambda gene cluster | 20.1 | 1 | 0 | 100 | 0 | 32 | 36 | ||
| 94 | IgG1 heavy chain constant region | 16.4 | 9 | 98 | 95 | 99 | 98 | 97 | ||
| 95 | 12.9 | 2 | 48 | 5 | 45 | 23 | ||||
| 96 | IGK protein | 10.0 | 10 | 0 | 2 | 99 | 34 | 29 | ||
| 97 | IgM heavy chain constant region | 22.7 | 53 | 100 | 100 | 100 | 100 | 100 | ||
| 98 | Inhibitor of carbonic anhydrase-like | 5.2 | 7 | 0 | 6 | 0 | 3 | 1 | ||
| 99 | Isocitrate dehydrogenase cytoplasmic | 12.1 | 5 | 0 | 0 | 14 | 6 | 2 | ||
| 100 | Isocitrate dehydrogenase cytoplasmic | 25.9 | 148 | 77 | 0 | 0 | 28 | 26 | ||
| 101 | Kappa-casein | 40.6 | 33 | 1 | 6 | 13 | 5 | 8 | ||
| 102 | Kappa-casein | 42.4 | 42 | 100 | 100 | 100 | 100 | 100 | ||
| 103 | Kappa-casein | 24.0 | 135 | 100 | 100 | 100 | 100 | 100 | ||
| 104 | Kappa-casein | 17.3 | 133 | 100 | 54 | 100 | 88 | 81 | ||
| 105 | Kappa-casein | 36.8 | 67 | 58 | 26 | 24 | 32 | 41 | ||
| 106 | Kappa-casein | 13.6 | 2 | 100 | 100 | 100 | 100 | 100 | ||
| 107 | Kappa-casein | 33.3 | 66 | 99 | 100 | 100 | 99 | 100 | ||
| 108 | Kappa-casein | 58.5 | 1 | 100 | 100 | 100 | 100 | 100 | ||
| 109 | Kappa-casein | 20.5 | 10 | 100 | 100 | 100 | 100 | 100 | ||
| 110 | Kappa-casein | 100.0 | 1 | 100 | 100 | 100 | 100 | 100 | ||
| 111 | Kappa-casein | 9.0 | 2 | 100 | 100 | 0 | 68 | 70 | ||
| 112 | Kappa-casein A | 57.1 | 33 | 100 | 100 | 100 | 100 | 100 | ||
| 113 | 11.6 | 13 | 99 | 0 | 26 | 36 | ||||
| 114 | 10.4 | 4 | 0 | 53 | 0 | 7 | ||||
| 115 | Kininogen-2 isoform X1 | 14.7 | 17 | 99 | 0 | 0 | 35 | 34 | ||
| 116 | 33.3 | 55 | 100 | 62 | 100 | 75 | ||||
| 117 | Lactoperoxidase | 26.1 | 144 | 36 | 0 | 36 | 23 | 25 | ||
| 118 | Lactoperoxidase | 5.1 | 12 | 100 | 100 | 100 | 100 | 100 | ||
| 119 | Lactotransferrin | 4.0 | 24 | 100 | 100 | 100 | 100 | 100 | ||
| 120 | Lactotransferrin | 53.1 | 134 | 98 | 0 | 0 | 35 | 33 | ||
| 121 | Lethal(3)malignant brain tumor-like protein 4 | 2.5 | 1 | 1 | 0 | 1 | 2 | 0 | ||
| 122 | Leucine proline-enriched proteoglycan (leprecan) 1 | 1.9 | 1 | 1 | 0 | 1 | 1 | 1 | ||
| 123 | Lipopolysaccharide-binding protein | 2.3 | 5 | 2 | 0 | 0 | 1 | 1 | ||
| 124 | Lipoprotein lipase | 22.0 | 152 | 100 | 99 | 100 | 100 | 99 | ||
| 125 | Lymphocyte antigen 96 | 6.3 | 9 | 3 | 0 | 0 | 1 | 2 | ||
| 126 | Lymphocyte-specific protein 1 isoform X6 | 5.8 | 4 | 3 | 0 | 0 | 1 | 2 | ||
| 127 | Mammaglobin-A | 14.1 | 1 | 10 | 0 | 0 | 7 | 0 | ||
| 128 | 9.2 | 11 | 17 | 1 | 0 | 0 | ||||
| 129 | Monocyte differentiation antigen CD14 isoform X1 | 22.7 | 25 | 82 | 0 | 68 | 47 | 52 | ||
| 130 | Mucin-1 | 3.1 | 13 | 100 | 7 | 8 | 43 | 37 | ||
| 131 | Mucin-15 | 7.3 | 10 | 99 | 100 | 94 | 97 | 98 | ||
| 132 | Myristoylated alanine-rich C-kinase substrate | 6.0 | 6 | 0 | 9 | 0 | 6 | 0 | ||
| 133 | Neutrophil gelatinase-associated lipocalin isoform X3 | 30.5 | 11 | 28 | 95 | 74 | 65 | 66 | ||
| 134 | Nucleobindin-1 | 28.1 | 117 | 100 | 0 | 38 | 48 | 46 | ||
| 135 | Nucleobindin-2 | 15.2 | 73 | 0 | 100 | 0 | 32 | 36 | ||
| 136 | Olfactory receptor 2S2-like | 2.2 | 1 | 0 | 4 | 1 | 2 | 1 | ||
| 137 | Osteopontin isoform X1 | 31.7 | 71 | 99 | 100 | 100 | 99 | 100 | ||
| 138 | Pancreatic elastase inhibitor | 66.7 | 1 | 10 | 0 | 0 | 1 | 6 | ||
| 139 | Pancreatic secretory granule membrane major glycoprotein GP2 | 23.0 | 84 | 100 | 96 | 100 | 100 | 98 | ||
| 140 | 13.7 | 5 | 0 | 15 | 63 | 13 | ||||
| 141 | Peptidyl-prolyl cis-trans isomerase A | 16.5 | 101 | 6 | 2 | 8 | 4 | 6 | ||
| 142 | Peptidyl-prolyl cis-trans isomerase B | 6.0 | 85 | 31 | 0 | 0 | 14 | 8 | ||
| 143 | Peptidyl-prolyl cis-trans isomerase FKBP1A | 25.0 | 98 | 7 | 0 | 0 | 2 | 2 | ||
| 144 | Perilipin-2 isoform X2 | 38.0 | 96 | 100 | 100 | 100 | 100 | 100 | ||
| 145 | Platelet glycoprotein 4 | 15.5 | 106 | 100 | 100 | 100 | 100 | 100 | ||
| 146 | Polymeric immunoglobulin receptor | 30.0 | 28 | 100 | 0 | 100 | 68 | 64 | ||
| 147 | Polymeric immunoglobulin receptor | 23.9 | 21 | 100 | 100 | 100 | 100 | 100 | ||
| 148 | Polyubiquitin | 21.0 | 380 | 0 | 79 | 0 | 24 | 29 | ||
| 149 | Prosaposin | 5.0 | 54 | 25 | 0 | 0 | 11 | 6 | ||
| 150 | Prostaglandin-H2 D-isomerase | 7.3 | 6 | 65 | 94 | 100 | 85 | 87 | ||
| 151 | Protein CREG1 | 20.4 | 11 | 78 | 0 | 13 | 30 | 33 | ||
| 152 | Protein HP-25 homolog 1 | 7.1 | 3 | 1 | 0 | 0 | 1 | 0 | ||
| 153 | 14.9 | 3 | 7 | 2 | 40 | 4 | ||||
| 154 | Protein inturned | 1.3 | 1 | 1 | 0 | 0 | 1 | 0 | ||
| 155 | Protein OS-9 | 4.5 | 2 | 5 | 0 | 1 | 2 | 2 | ||
| 156 | Prothrombin | 2.2 | 7 | 6 | 1 | 0 | 2 | 3 | ||
| 157 | Ras-related protein Rab-11A | 11.1 | 82 | 1 | 0 | 0 | 1 | 0 | ||
| 158 | Ras-related protein Rab-18 | 7.3 | 123 | 3 | 0 | 0 | 1 | 2 | ||
| 159 | Rhophilin-2-like protein RHPN2P1 | 2.4 | 2 | 0 | 1 | 0 | 1 | 0 | ||
| 160 | Ribonuclease 4 | 9.2 | 1 | 0 | 81 | 0 | 30 | 25 | ||
| 161 | Ribonuclease 4 | 28.6 | 4 | 31 | 0 | 3 | 12 | 11 | ||
| 162 | Ribonuclease pancreatic | 10.5 | 100 | 0 | 19 | 0 | 3 | 10 | ||
| 163 | Secretoglobin family 1D member | 21.6 | 4 | 100 | 100 | 100 | 100 | 100 | ||
| 164 | Selenium-binding protein 1 | 1.7 | 1 | 8 | 0 | 3 | 3 | 4 | ||
| 165 | Selenoprotein | 13.0 | 69 | 45 | 0 | 9 | 23 | 14 | ||
| 166 | Serotransferrin | 45.5 | 61 | 100 | 95 | 100 | 100 | 97 | ||
| 167 | 12.9 | 32 | 100 | 0 | 77 | 51 | ||||
| 168 | Serum albumin | 65.1 | 40 | 100 | 61 | 100 | 83 | 90 | ||
| 169 | Sodium-dependent phosphate transport protein 2B | 5.9 | 7 | 92 | 0 | 0 | 35 | 29 | ||
| 170 | Sulfhydryl oxidase 1 | 19.1 | 11 | 98 | 27 | 97 | 75 | 72 | ||
| 171 | Superoxide dismutase | 11.8 | 73 | 0 | 1 | 0 | 0 | 1 | ||
| 172 | Sushi repeat-containing protein SRPX | 3.9 | 3 | 0 | 2 | 6 | 2 | 4 | ||
| 173 | Tetranectin | 6.9 | 5 | 89 | 0 | 1 | 34 | 29 | ||
| 174 | Transforming protein RhoA | 6.2 | 49 | 0 | 0 | 1 | 1 | 0 | ||
| 175 | Transthyretin | 34.7 | 24 | 0 | 91 | 77 | 59 | 50 | ||
| 176 | Uncharacterized protein | 33.5 | 5 | 18 | 0 | 0 | 7 | 6 | ||
| 177 | Uncharacterized protein | 17.2 | 16 | 99 | 0 | 0 | 35 | 34 | ||
| 178 | 20.6 | 10 | 42 | 0 | 0 | 10 | ||||
| 179 | Uncharacterized protein | 21.1 | 4 | 1 | 0 | 6 | 5 | 0 | ||
| 180 | 6.3 | 99 | 98 | 0 | 41 | 37 | ||||
| 181 | Uncharacterized protein | 20.9 | 1 | 0 | 100 | 0 | 32 | 36 | ||
| 182 | Uncharacterized protein LOC524810 | 10.9 | 6 | 100 | 100 | 100 | 100 | 100 | ||
| 183 | 8.0 | 20 | 38 | 0 | 0 | 6 | ||||
| 184 | Xanthine dehydrogenase/oxidase | 15.6 | 16 | 0 | 100 | 0 | 32 | 36 | ||
| 185 | Xanthine dehydrogenase/oxidase | 14.1 | 16 | 100 | 0 | 100 | 68 | 64 | ||
| 186 | Zinc-alpha-2-glycoprotein | 11.4 | 2 | 1 | 100 | 100 | 64 | 67 | ||
Proteins whose occurrence varies more than 10% across breeds are highlighted in bold.
Occurrence is defined as the ratio of the number of samples in which the protein was identified over the total number of samples in the method or breed expressed in percent.
Amino acid sequence of uncharacterized proteins were blasted against uniprot database. Best hit is indicated in brackets with the percentage of identity.
Figure 2Comparison of SDS-PAGE patterns (top panel), protein concentration (middle panel), and number of protein accessions identified per sample (bottom panel). Error bars are Standard Deviation (SD); the n number displayed at the top right corner of each box represents the number of replicates used for average and SD. Error bars for the protein assay are from the BCA technical triplicates. Error bars for the accession numbers are from 15 replicates (5 digestion replicates × 3 injection replicates). Recovery rates are indicated in percent in the protein assay and are computed relative to protein concentrations in skim milk (SM). SA, Serum Albumin; aCN, alpha-casein; bCN, beta-casein, bLG, beta-lactoglobulin; aLA, alpha-lactalbumin.
Figure 3Total Ion Chromatograms (TIC) of three tryptic digests illustrating the effect of extraction method for Holstein-Friesian (left panel) or Jersey (right panel) breed. A TIC represents the summed intensity across the entire range of masses being detected at every point in the analysis. The duration of each nLC run is 50 min (x-axis), with tryptic peptides eluting from 10 to 42 min. Relative abundance (percent relative abundance with respect to the ion of highest abundance along the y-axis) of the most intense chromatographic peaks are comparable across methods. Most abundant peaks elute toward the end of the nLC run (27–38 min) for methods A (urea) and B (TCA/acetone), while they are evenly distributed along the whole elution pattern (11–38 min) for method C (methanol/chloroform). Subtle differences in peptide elution are visible between Holstein-Friesian (left panel) and Jersey (right panel) breeds. The nomenclature of each TIC exemplified here is explained in the Materials and Method Section and in Figure 1.
Figure 4TIC of 45 Jersey tryptic digests illustrating the reproducibility at digestion (5 replicates) and injection (3 replicates) levels, for methods A (urea) (15 replicates), B (TCA/acetone) (15 replicates), and C (methanol/chloroform) (15 replicates). TICs of each set of three randomized repeated injections are alternatively black or gray. The x-axis represents the duration of the nLC run in min, while the y-axis represents the relative abundance of the chromatographic peaks which corresponds to the percent relative abundance with respect to the ion of highest abundance. With the exception of the inconsistent peptides eluting very early (10–12 min) or very late (39–42 min) during the 50 min nLC run, TICs are very reproducible across technical replicates, within a particular method. The nomenclature of each TIC exemplified here is explained in the Materials and Method Section and in Figure 1.
Figure 5Principal component analyses (PCA) plots along Principal Component (PC) 1 against PC2 (left panel), and PC1 against PC7 (right panel). Together PC1 (19.9%) and PC2 (13.8%) explain 33.7% of the total variance and clearly separate the three methods. Within each method, all replicates cluster together whether it be at the extraction, digestion or injection levels. Breed explain 2.1% of the variance along PC7. On the plot PC1 against PC7, methods and breed are well-separated.
Figure 6Partial Least Square (PLS) analysis plots along Latent Variable (LV) 1 against LV2. Together LV1 (22.7%) and LV2 (16.7%) explain 39.4% of the total variance, with a clear separation of breeds and methods, and displaying six tight clusters for JA, JB, JC, HA, HB, and HC.
Figure 7Venn diagram of the number of unique protein accessions and Gene Ontology (GO) classification of known proteins per extraction method. A, method A (urea); B, method B (TCA/acetone); C, method C (methanol/chloroform); AB, methods A and B combined; AC, methods A and C combined; BC, methods B and C combined; ABC, methods A, B, and C combined. On the histograms illustrating GO classifications, the x-axis represents the square root of the number of proteins belonging to each of the classes distributed along the y-axis. The insets illustrate the histograms of the sub-classes of the GO class containing the greatest number of proteins.
List of protein accessions identified in the combined protein standards, along with their description, their score, coverage, the number of peptides identified per protein, the number of peptide spectrum matches (PSM), the size of the protein (AA and MW) and their theoretical isoelectric point (calc. pI).
| 1 | 11 kDa protein | 124.2 | 29.0 | 2 | 2 | 107 | 11.1 | 7.99 | |
| 2 | |||||||||
| 3 | |||||||||
| 4 | Alpha-1-acid glycoprotein | 84.3 | 15.4 | 3 | 3 | 202 | 23.2 | 5.87 | |
| 5 | |||||||||
| 6 | |||||||||
| 7 | |||||||||
| 8 | |||||||||
| 9 | |||||||||
| 10 | |||||||||
| 11 | |||||||||
| 12 | Antibody Blv1h12 | 221.5 | 23.2 | 3 | 5 | 216 | 22.5 | 6.11 | |
| 13 | Apolipoprotein A-II precursor [Bos taurus] | 73.4 | 16.0 | 2 | 2 | 100 | 11.2 | 8.10 | |
| 14 | APOLIPOPROTEIN C-III precursor [Bos taurus] | 108.3 | 16.7 | 2 | 4 | 96 | 10.7 | 5.11 | |
| 15 | Beta-2-microglobulin precursor [Bos taurus] | 148.9 | 18.6 | 6 | 9 | 118 | 13.7 | 8.00 | |
| 16 | |||||||||
| 17 | |||||||||
| 18 | |||||||||
| 19 | |||||||||
| 20 | Complement C3 | 179.6 | 4.5 | 10 | 10 | 1661 | 187.1 | 6.84 | |
| 21 | |||||||||
| 22 | |||||||||
| 23 | |||||||||
| 24 | |||||||||
| 25 | |||||||||
| 26 | Fibronectin isoform X10 [Bos taurus] | 292.9 | 5.0 | 14 | 14 | 2268 | 249.0 | 5.63 | |
| 27 | Glycoprotein 2 (zymogen granule membrane) [Bos taurus] | 81.7 | 2.8 | 2 | 2 | 534 | 59.2 | 4.82 | |
| 28 | Immunoglobulin lambda light chain IGLC2c [Bos taurus] | 160.6 | 42.5 | 3 | 4 | 106 | 11.4 | 8.59 | |
| 29 | Immunoglobulin light chain [Bos taurus] | 118.9 | 30.7 | 2 | 2 | 101 | 10.4 | 6.48 | |
| 30 | |||||||||
| 31 | |||||||||
| 32 | |||||||||
| 33 | |||||||||
| 34 | |||||||||
| 35 | |||||||||
| 36 | |||||||||
| 37 | Lactoperoxidase precursor [Bos taurus] | 58.8 | 1.5 | 2 | 2 | 712 | 80.6 | 8.54 | |
| 38 | |||||||||
| 39 | |||||||||
| 40 | Neutrophil gelatinase-associated lipocalin isoform X3 [Bos taurus] | 168.8 | 16.0 | 4 | 6 | 200 | 23.0 | 9.17 | |
| 41 | Plasminogen isoform X3 [Bos taurus] | 103.2 | 4.6 | 3 | 4 | 724 | 81.5 | 7.96 | |
| 42 | Polymeric immunoglobulin receptor | 130.9 | 5.9 | 5 | 5 | 757 | 82.4 | 7.27 | |
| 43 | Ribonuclease 4 precursor [Bos taurus] | 122.2 | 28.6 | 6 | 6 | 147 | 16.9 | 8.85 | |
| 44 | Secretoglobin family 1D member precursor [Bos taurus] | 83.1 | 21.6 | 4 | 4 | 102 | 11.3 | 8.73 | |
| 45 | Serotransferrin | 117.9 | 7.7 | 6 | 6 | 704 | 77.7 | 7.08 | |
| 46 | Serotransferrin [Myotis brandtii] | 70.8 | 4.1 | 2 | 2 | 713 | 77.9 | 7.05 | |
| 47 | Tropomyosin alpha-3 chain isoform 2 [Homo sapiens] | 51.4 | 4.0 | 2 | 2 | 248 | 29.0 | 4.78 | |
| 48 | |||||||||
| 49 | Uncharacterized protein | 228.2 | 18.7 | 7 | 7 | 443 | 50.2 | 5.72 | |
| 50 | Uncharacterized protein | 532.4 | 29.2 | 6 | 23 | 161 | 18.3 | 5.19 | |
| 51 | Uncharacterized protein LOC102338350 [Pantholops hodgsonii] | 60.0 | 4.1 | 1 | 4 | 245 | 28.1 | 9.70 |
As the purity level of each standard varied, expected known proteins are highlighted in bold.
Figure 8Validation of protein identities using known protein standards. One peptide per standard was selected and Extracted Ion Chromatograms (EICs) were produced and compared across the standard mixture, Jersey bulk milk, and Holstein bulk mik tryptic digests. Retention times (RT) are comparable across samples. The MS/MS spectrum of the selected peptide is displayed below the EICs. Insets indicate the proteins to which this peptide belongs, the AA sequence of the selected peptide, its m/z, charge state and RT. (A), peptide from beta actin; (B), peptide from alpha S1 casein; (C), peptide from alpha S2 casein; (D), peptide from beta casein; (E), peptide from kappa casein; (F), peptide from alpha lactalbumin; (G), peptide from beta lactoglobulin; (H), peptide from bovine serum albumin; (I), peptide from fibrinogen; (J), peptide from kininogen; (K), peptide from lactotransferrin.